Neuroscience
FierceBiotechResearch has an article which presents a very brief overview of the current Alzheimer's disease drug pipeline:
It is available at the link below:
Making sense of the Alzheimer's drug pipeline
FierceBiotechResearch
March 15, 2011 — 7:53am ET
By Howard Lovy
Read the full article
If this area is new to you, the article will give you the names of some candidates that you can learn about as part of your introduction. There are many other overview articles and public resources available to you concerning clinical-trials research. You might wish, for example, to cross reference the names cited here with the ClinicalTrials.gov database.
If you are a Brain Awareness Week visitor, you can visit the Alzheimer's Association or other national organizations in your country to learn more about Alzheimer's disease and dementia.
- Alzheimer Disease: Discussions About Bexarotene
Discussions about Targretin (bexarotene): From The Wall Street Journal: Alzheimer's Families Clamor for Drug By Shirley S. Wang 11 February 2012 Read the article From the In The Pipeline blog: Bexarotene for Alzheimer's 13 February 2012 Read the...
- World Alzheimer's Day
Today is World Alzheimer's Day. Read something today to increase your knowledge about the disease and dementia. Here's a general-readership resource: Alzheimer's Disease: Unraveling the Mystery ... and a report from the Alzheimer's Association:...
- Upcoming Event:alzheimer's Drug Discovery (jersey City, Nj, 14-15 September)
The 10th international conference on Alzheimer's disease drug discovery takes place next week on the 14th and 15th in Jersey City, NJ. From the conference website: "The 10th International Conference on Alzheimer's Disease Drug Discovery is presented...
- Upcoming Event: Alzheimer Disease (las Vegas, 29-30 Oct 2009)
2nd Conference on Clinical Trials on Alzheimer’s Disease (CTAD) From the conference website: "Dear Colleague, "It is a great pleasure for us to invite you to attend the 2nd conference Clinical Trials on Alzheimer’s Disease (CTAD), which will take...
- Reminyl (galantamine Hydrobromide) (continued)
Safety Concerns Reported on J.& J. Alzheimer's Drug By ANDREW POLLACK New York Times Published: January 22, 2005 Regulators are reviewing the safety of the Alzheimer's disease drug Reminyl after data from two clinical trials indicated...
Neuroscience
Alzheimer's: The Current Pipeline
FierceBiotechResearch has an article which presents a very brief overview of the current Alzheimer's disease drug pipeline:
It is available at the link below:
Making sense of the Alzheimer's drug pipeline
FierceBiotechResearch
March 15, 2011 — 7:53am ET
By Howard Lovy
Read the full article
If this area is new to you, the article will give you the names of some candidates that you can learn about as part of your introduction. There are many other overview articles and public resources available to you concerning clinical-trials research. You might wish, for example, to cross reference the names cited here with the ClinicalTrials.gov database.
If you are a Brain Awareness Week visitor, you can visit the Alzheimer's Association or other national organizations in your country to learn more about Alzheimer's disease and dementia.
- Alzheimer Disease: Discussions About Bexarotene
Discussions about Targretin (bexarotene): From The Wall Street Journal: Alzheimer's Families Clamor for Drug By Shirley S. Wang 11 February 2012 Read the article From the In The Pipeline blog: Bexarotene for Alzheimer's 13 February 2012 Read the...
- World Alzheimer's Day
Today is World Alzheimer's Day. Read something today to increase your knowledge about the disease and dementia. Here's a general-readership resource: Alzheimer's Disease: Unraveling the Mystery ... and a report from the Alzheimer's Association:...
- Upcoming Event:alzheimer's Drug Discovery (jersey City, Nj, 14-15 September)
The 10th international conference on Alzheimer's disease drug discovery takes place next week on the 14th and 15th in Jersey City, NJ. From the conference website: "The 10th International Conference on Alzheimer's Disease Drug Discovery is presented...
- Upcoming Event: Alzheimer Disease (las Vegas, 29-30 Oct 2009)
2nd Conference on Clinical Trials on Alzheimer’s Disease (CTAD) From the conference website: "Dear Colleague, "It is a great pleasure for us to invite you to attend the 2nd conference Clinical Trials on Alzheimer’s Disease (CTAD), which will take...
- Reminyl (galantamine Hydrobromide) (continued)
Safety Concerns Reported on J.& J. Alzheimer's Drug By ANDREW POLLACK New York Times Published: January 22, 2005 Regulators are reviewing the safety of the Alzheimer's disease drug Reminyl after data from two clinical trials indicated...